myelodysplastic syndromes
Conditions
Interventions
Two groups:Traditional Chinese Medicine compound Qinghuang powder will be given by different doses.
Sponsors
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. meet the diagnostic criteria for Western medicine MDS and voluntary treatment of traditional Chinese medicine Qinghuang powder treatment; 2. voluntarily tested and signed informed consent; 3. did not participate in other clinical researchers; 4. in the age range of 18-80 years old due to the aging of the disease tendencies.
Exclusion criteria
Exclusion criteria: 1. combined with serious intentions, liver, kidney and peripheral neurological disease; 2. mental illness can not cooperate with the treatment of patients; 3. pregnancy, lactating women; 4. less than 18 years of age, more than 80 years of age; 5. participate in other clinical researchers; 6. patients can not cooperate or do not sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood arsenic concentration; | — |
Countries
China
Contacts
Public ContactHu Xiaomei
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed